Modified Busulfan and Cyclophosphamide Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Patients With Hematologic Malignancies-Reference-Cited by-同舟云学术

Modified Busulfan and Cyclophosphamide Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Patients With Hematologic Malignancies

Published:2014-06 Issue:5 Volume:46 Page:1531-1535
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Zhao X.F.,Mao X.Y.,Wan D.M.,Liu W.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference28 articles.

1. Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation;de Lima;Blood,2004

2. Increasing utilization of bone marrow transplantation: II. Results of the 1985-1987 survey;Bortin;Transplantation,1989

3. Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning;Hari;Biol Blood Marrow Transplant,2008

4. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease;Greinix;Blood,1998

5. Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age;Deeg;Blood,2000

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell transplantation;Annals of Hematology;2024-06-20

2. Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell transplantation.;2024-01-03

3. Decitabine-Intensified Modified Busulfan/Cyclophosphamide Conditioning Regimen Improves Survival in Acute Myeloid Leukemia Patients Undergoing Related Donor Hematopoietic Stem Cell Transplantation: A Propensity Score Matched Analysis;Frontiers in Oncology;2022-03-16

4. Role of antithymocyte globulin in matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies;Medicine;2021-02-26

5. Reduced risk of chronic GVHD by low-dose rATG in adult matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies;Annals of Hematology;2019-12-11